Toshiaki Shirakata - Concepedia

Author

Toshiaki Shirakata

The University of Osaka

Also Known As

T SHIRAKATA, T Shirakata, T. Shirakata, Toshiaki Shirakata

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

The University of Osaka Cancer Australia Kyoto University Ehime University Nagoya University

About

Toshiaki Shirakata is an author at The University of Osaka specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	1K
2	Immunology	12	13	1K
3	Cell Biology	5	5	257
4	Health Sciences	2	2	28
5	Molecular Genetics	1	1	16

Toshiaki Shirakata

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Induction of <i>WT1</i> (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression Akihiro Tsuboi, Tetsuya Taguchi, Tadashi Osaki, Proceedings of the National Academy of Sciences Cytotoxic T LymphocytesWt1 PeptideImmune RegulationImmunologyImmunodominance	2004	524
Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme Shuichi Izumoto, Akihiro Tsuboi, Tsuyoshi Suzuki, Journal of neurosurgery	2008	208
Overexpression of the Wilms' tumor gene <i>WT1</i> in primary astrocytic tumors Yusuke Oji, Tsuyoshi Suzuki, Yoko Nakano, Cancer Science	2004	122
Novel adoptive T-cell immunotherapy using a WT1-specific TCR vector encoding silencers for endogenous TCRs shows marked antileukemia reactivity and safety Toshiki Ochi, Hiroshi Fujiwara, Sachiko Okamoto, Blood	2011	120
AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with the Wilms tumor gene, WT1 Sumiyuki Nishida, Naoki Hosen, Toshiaki Shirakata, Blood	2005	119
Antiapoptotic function of 17AA(+)WT1 (Wilms' tumor gene) isoforms on the intrinsic apoptosis pathway Ken Ito, Yusuke Oji, Naoya Tatsumi, Oncogene Antiapoptotic FunctionCancer ResearchIntrinsic Apoptosis PathwayOncogenic AgentMedicine	2006	106
The Wilms’ tumor gene WT1-GFP knock-in mouse reveals the dynamic regulation of WT1 expression in normal and leukemic hematopoiesis Naoki Hosen, Toshiaki Shirakata, Sumiyuki Nishida, Leukemia Dynamic RegulationHematological MalignancyKnockout MouseImmunologyHematology	2007	96
A Phase I/II Trial of a WT1 (Wilms' Tumor Gene) Peptide Vaccine in Patients with Solid Malignancy: Safety Assessment Based on the Phase I Data Satoshi Morita, Akihiro Tsuboi, Manabu Kawakami, Japanese Journal of Clinical Oncology	2006	83
WT1 (Wilms' Tumor 1) Peptide Immunotherapy for Renal Cell Carcinoma Tatsuo Iiyama, Keiko Udaka, Sachihiko Takeda, Microbiology and Immunology	2007	78
Wilms' tumor gene WT1-shRNA as a potent apoptosis-inducing agent for solid tumors Naoya Tatsumi, Yusuke Oji, Naoko Tsuji, International Journal of Oncology	2008	77

Page 1